Elon Musk Says Ozempic 'Will Become Very Cheap' After New Comedy Special Paints It As Weight Loss Drug Only Wealthy People Can Afford
Elon Musk Says Ozempic 'Will Become Very Cheap' After New Comedy Special Paints It As Weight Loss Drug Only Wealthy People Can Afford
Tesla and SpaceX CEO Elon Musk made a bold prediction about the future cost of Novo Nordisk's (NYSE:NVO) Ozempic, a popular drug being used for weight loss.
特斯拉和SpaceX首席執行官埃隆·馬斯克對諾和諾德（紐約證券交易所代碼：NVO）的Ozempic的未來成本做出了大膽的預測，Ozempic是一種流行的減肥藥物。
What Happened: Musk's comments came after a new South Park special portrayed the drug as a luxury only available to the wealthy.
發生了什麼：馬斯克的評論是在南方公園的一部新特別節目將這種藥物描繪成只有富人才能獲得的奢侈品之後發表的。
On Saturday, Mario Nawfal took to X, formerly Twitter, and highlighted the comedy special titled, "The End of Obesity," saying in the show Ozempic is depicted as a weight loss medication accessible only to affluent individuals, juxtaposing Lizzo's music as a form of solace for those struggling with weight issues and economic challenges.
週六，Mario Nawfal在X（前身爲Twitter）上重點介紹了名爲 “肥胖的終結” 的喜劇特別節目，他在節目中說，Ozempic被描繪成一種只有富人才能獲得的減肥藥物，將Lizzo的音樂作爲對那些在體重問題和經濟挑戰中掙扎的人的慰藉。
Musk commented on his post, saying, "It will become very cheap."
馬斯克評論了他的帖子，他說：“它將變得非常便宜。”
It will become very cheap
— Elon Musk (@elonmusk) May 25, 2024
它會變得非常便宜
— 埃隆·馬斯克 (@elonmusk) 2024 年 5 月 25 日
"South Park: The End of Obesity" debuted on May 24 in the U.S. and Canada, followed by several other countries on May 25. The special will be available for streaming on Paramount+, which is owned by Paramount Global.
《南方公園：肥胖的終結》於5月24日在美國和加拿大首次亮相，隨後於5月25日在其他幾個國家首次亮相。該特別節目將在派拉蒙環球旗下的派拉蒙+上直播。
Why It Matters: Over the past year, Novo Nordisk's top weight loss medications Wegovy and Ozempic have contributed to the company's stock growth. Similarly, Eli Lilly And Co's (NYSE:LLY) weight-loss drug Mounjaro has led to an increase in its share value.
爲何重要：在過去的一年中，諾和諾德的頂級減肥藥物Wegovy和Ozempic爲公司的股票增長做出了貢獻。同樣，禮來公司（紐約證券交易所代碼：LLY）的減肥藥物Mounjaro也導致其股價上漲。
In March earlier this year, U.S. Senator Bernie Sanders called the drug's price "outrageous" and mooted a meeting with Novo Nordisk's CEO to discuss the issue. "This outrageously high price has the potential to bankrupt Medicare, the American people, and our entire health care system," he said then, adding, "We cannot allow that to happen."
今年3月，美國參議員伯尼·桑德斯稱該藥的價格 “令人髮指”，並提議與諾和諾德首席執行官會面討論這個問題。他當時說：“這種高得離譜的價格有可能使醫療保險、美國人民和我們的整個醫療保健系統破產，” 他補充說，“我們不能允許這種情況發生。”
Earlier this month, Australia banned replica versions of popular weight-loss drugs, including Ozempic and Mounjaro, due to safety concerns.
本月早些時候，出於安全考慮，澳大利亞禁止了包括Ozempic和Mounjaro在內的流行減肥藥物的仿製版本。
Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
免責聲明： 該內容部分是在... 的幫助下製作的 本辛加神經 並由 Benzinga 編輯審閱和出版。
Image Via Shutterstock
圖片來自 Shutterstock